BioLife Solutions
BLFS
38.61
0.00
0.00%
BioLife Solutions
US · BLFS
#2844 by market cap
Listed 1970
38.61
0.00
0.00%
Live - 5344 symbols - heartbeat 462s ago
· 2026-10-07 19:54
- Market cap
- 1.89B
- P/E (TTM)i
- 32.72
- P/Bi
- 4.50
- EPSi
- -0.10
- Div yieldi
- 0.00%
- 52W posi
- 95%
Reader sentiment
Are you bullish or bearish on BLFS?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $31Market Newswire · 2025/11/8
-
Benchmark Co. Downgrades BioLife Solutions(BLFS.US) to Hold RatingMarket Newswire · 2026/8/10
-
Rating change
H.C. Wainwright Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/6/1
-
Stephens Downgrades BioLife Solutions(BLFS.US) to Hold Rating, Raises Target Price to $31Market Newswire · 2026/7/27
-
Rating change
Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy RatingMarket Newswire · 2026/6/25
-
Rating change
Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), Biohaven Ltd. (BHVN) and BioLife Solutions (BLFS)TipRanks · 2026/6/25
-
Rating change
Analysts' Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), BioLife Solutions (BLFS)TipRanks · 2026/5/14
-
Rating change
TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $33Market Newswire · 2026/5/8
-
Rating change
Maxim Group Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $34Market Newswire · 2026/5/14
-
Rating change
Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $34Market Newswire · 2026/1/5
-
Rating change
Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $34Market Newswire · 2026/3/24
-
Rating change
Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $33Market Newswire · 2026/5/8
-
Maxim Group Maintains BioLife Solutions(BLFS.US) With Hold RatingMarket Newswire · 2026/7/24
-
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $28.5M, Vs. FactSet Est of $27.8MMT Newswires · 2026/8/7
-
Rating change
Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $32Market Newswire · 2026/5/8
-
Company notice
BioLife Solutions: BioLife Solutions, Inc. - Anticipated Adjustment Option Symbol: BLFS New Symbol: RGEN1OCC · 2026/9/10
-
Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Hold RatingMarket Newswire · 2026/9/30
-
Rating change
A Quick Look at Today's Ratings for BioLife Solutions(BLFS.US), With a Forecast Between $31 to $31Market Newswire · 2026/7/23
-
Rating change
Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $33Market Newswire · 2025/11/8
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.